Harrow (HROW) Operating Margin (2013 - 2026)
Harrow's (HROW) quarterly Operating Margin came in at 49.95% in Q1 2026, down 2647.0% year-on-year from 1.96% in Q1 2025, and down 385.44% quarter-over-quarter from 17.5% in Q4 2025.
Harrow (HROW) Operating Margin (2013 - 2026) Analysis & Trends
Harrow's Operating Margin history runs 14 years deep, the most recent figure standing at 49.95% for Q1 2026.
- On a quarterly basis, Operating Margin fell 2647.0% year-over-year to 49.95% in Q1 2026; TTM through Mar 2026 was 7.32%, a 520.0% increase from a year earlier, with the FY2025 full-year figure at 11.21%, up 679.0% from the prior year.
- Operating Margin retreated to 49.95% in Q1 2026 per HROW's latest filing, from 17.5% in the prior quarter.
- Across five years, Operating Margin topped out at 20.59% in Q3 2025 and bottomed at 49.95% in Q1 2026.
- The 5-year median for Operating Margin is 4.64% (2023), against an average of 0.08%.
- Across the five-year window, Operating Margin soared 3271 bps in 2024 and slumped 2647 bps in 2026, its largest moves.
- Year by year, Operating Margin stood at 8.75% in 2022, then slumped by 53 bps to 13.41% in 2023, then jumped by 244 bps to 19.3% in 2024, then decreased by 9 bps to 17.5% in 2025, then slumped by 385 bps to 49.95% in 2026.
- Per Business Quant, the three latest HROW Operating Margin figures stand at 49.95% (Q1 2026), 17.5% (Q4 2025), and 20.59% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.37% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 36.83% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -38.02% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 41.69% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -2.27% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 23.74% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.23% |
| 10 | Harrow | 1.56 Bn | 1.47 Bn | 27.05 Mn | -49.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -49.95% |
| Dec 31, 2025 | 17.50% |
| Sep 30, 2025 | 20.59% |
| Jun 30, 2025 | 17.90% |
| Mar 31, 2025 | -23.48% |
| Dec 31, 2024 | 19.30% |
| Sep 30, 2024 | 2.68% |
| Jun 30, 2024 | 3.13% |
| Mar 31, 2024 | -20.03% |
| Dec 31, 2023 | -13.41% |
| Sep 30, 2023 | 5.09% |
| Jun 30, 2023 | 7.03% |
| Mar 31, 2023 | 4.64% |
| Dec 31, 2022 | -8.75% |
| Sep 30, 2022 | -0.41% |
| Jun 30, 2022 | 7.25% |
| Mar 31, 2022 | 9.50% |
| Dec 31, 2021 | -8.69% |
| Sep 30, 2021 | -19.87% |
| Jun 30, 2021 | 22.99% |